Cerebrospinal fluid markers of neuronal and glial cell damage in patients with autoimmune neurologic syndromes with and without underlying malignancies

被引:15
作者
Constantinescu, Radu [1 ,7 ]
Krysl, David [1 ,7 ]
Andren, Kerstin [1 ,7 ]
Asztely, Fredrik [1 ,5 ]
Bergquist, Filip [1 ,7 ]
Zetterberg, Henrik [2 ,3 ,4 ]
Andreasson, Ulf [2 ,3 ]
Axelsson, Markus [1 ,7 ]
Ben Menachem, Elinor [1 ,7 ]
Jons, Daniel [1 ,7 ]
Mahamud, Ubah [1 ,7 ]
Malmestrom, Clas [1 ,6 ,7 ]
Rosengren, Lars [1 ,7 ]
Blennow, Kaj [2 ,3 ]
机构
[1] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden
[2] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Inst Neurosci & Physiol, Molndal, Sweden
[3] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden
[4] UCL, Inst Neurol, Queen Sq, London WC1N 3BG, England
[5] Auckland Univ, Dept Neurol, Waikato Clinical Campus, Auckland, New Zealand
[6] Sahlgrens Univ Hosp, Clin Immunol Lab, Gothenburg, Sweden
[7] Sahlgrens Univ Hosp, Dept Neurol, S-41345 Gothenburg, Sweden
关键词
Autoimmune neurological syndrome; Paraneoplastic neurologic syndrome; Non-paraneoplastic; Autoimmune encephalitis; Neurofilament light chain; Tau protein; CENTRAL-NERVOUS-SYSTEM; PARANEOPLASTIC SYNDROMES; LIMBIC ENCEPHALITIS; DIAGNOSIS; ANTIBODIES; DISEASE;
D O I
10.1016/j.jneuroim.2017.02.018
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Autoimmune neurologic syndromes can be paraneoplastic (associated with malignancies and/or onconeural antibodies), or non-paraneoplastic Their clinical presentation is often similar. As prognosis is related to malignancy treatment, better biomarkers are needed to identify patients with malignancy. We investigated cerebrospinal fluid (CSF) markers of neuronal (neurofilament light chain, NFL and total tau protein, T-tau) and glial (glial fibrillary acidic protein) damage. CSF-NFL and T-tau were increased in both paraneoplastic and non-paraneoplastic autoimmune syndromes. Patients with manifest malignancies were older, had less epilepsy, more focal central and peripheral neurological signs and symptoms, and worse long-term outcome, than those without malignancy. CSF-NFL-levels predicted long-term outcome but were not diagnostic for malignancy, after age adjustment. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:25 / 30
页数:6
相关论文
共 22 条
  • [1] The diagnosis and treatment of limbic encephalitis
    Asztely, F.
    Kumlien, E.
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2012, 126 (06): : 365 - 375
  • [2] PROTEIN-ANALYSIS IN CEREBROSPINAL-FLUID .2. REFERENCE VALUES DERIVED FROM HEALTHY-INDIVIDUALS 18-88 YEARS OF AGE
    BLENNOW, K
    FREDMAN, P
    WALLIN, A
    GOTTFRIES, CG
    KARLSSON, I
    LANGSTROM, G
    SKOOG, I
    SVENNERHOLM, L
    WIKKELSO, C
    [J]. EUROPEAN NEUROLOGY, 1993, 33 (02) : 129 - 133
  • [3] Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
    Blennow, Kaj
    Hampel, Harald
    Weiner, Michael
    Zetterberg, Henrik
    [J]. NATURE REVIEWS NEUROLOGY, 2010, 6 (03) : 131 - 144
  • [4] Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis
    Constantinescu, R.
    Krysl, D.
    Bergquist, F.
    Andren, K.
    Malmestroem, C.
    Asztely, F.
    Axelsson, M.
    Menachem, E. B.
    Blennow, K.
    Rosengren, L.
    Zetterberg, H.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 (04) : 796 - 806
  • [5] THE USE OF THE KARNOFSKY PERFORMANCE SCALE IN DETERMINING OUTCOMES AND RISK IN GERIATRIC OUTPATIENTS
    CROOKS, V
    WALLER, S
    SMITH, T
    HAHN, TJ
    [J]. JOURNALS OF GERONTOLOGY, 1991, 46 (04): : M139 - M144
  • [6] Paraneoplastic syndromes of the CNS
    Dalmau, Josep
    Rosenfeld, Myrna R.
    [J]. LANCET NEUROLOGY, 2008, 7 (04) : 327 - 340
  • [7] Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
    Dalmau, Josep
    Lancaster, Eric
    Martinez-Hernandez, Eugenia
    Rosenfeld, Myrna R.
    Balice-Gordon, Rita
    [J]. LANCET NEUROLOGY, 2011, 10 (01) : 63 - 74
  • [8] Paraneoplastic syndromes involving the nervous system
    Darnell, RB
    Posner, JB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (16) : 1543 - 1554
  • [9] THE UNITED-KINGDOM TRANSIENT ISCHEMIC ATTACK (UK-TIA) ASPIRIN TRIAL - FINAL RESULTS
    FARRELL, B
    GODWIN, J
    RICHARDS, S
    WARLOW, C
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1991, 54 (12) : 1044 - 1054
  • [10] Sub-acute cerebellar degeneration with anti-Yo autoantibodies: immunohistochemical analysis of the immune reaction in the central nervous system
    Giometto, B
    Marchiori, GC
    Nicolao, P
    Scaravilli, T
    Lion, A
    Bardin, PG
    Tavolato, B
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1997, 23 (06) : 468 - 474